Oncology
 |
|
29 november 2019 07:01:19 |
| Regorafenib in patients with refractory metastatic pancreatic cancer: a Phase II study (RESOUND) (Future Oncology) |
|
Tweet Future Oncology, Volume 15, Issue 35, Page 4009-4017, December 2019. |
| 219 viewsCategory: Oncology |
 Dissimilar associations of same metabolic parameters with main chronic noncommunicable diseases (cancer vs some other NCDs) (Future Oncology)A lncRNA coordinates with Ezh2 to inhibit HIF-1? transcription and suppress cancer cell adaption to hypoxia (Oncogene) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
